Health Canada approves Rinvoq for the treatment of adults with active psoriatic arthritis- AbbVie Canada

“Psoriatic arthritis is a debilitating disease that can cause severe pain, restricted mobility, and lasting structural damage. The immune system creates inflammation that can lead to skin lesions associated with psoriasis, as well as pain, fatigue and stiffness in the joints,” said Dr. Proton Rahman, FRCPC, Clinical Rheumatologist at Eastern Health and University Research Professor at Memorial University. “Despite treatment advances, some people living with PsA do not achieve their treatment goals, which is why access to new therapies is so critical.